Zhe Dong Selected Research

Zhe Dong Research Topics

Disease

17	Neoplasms (Cancer) 05/2024 - 02/2013
5	Inflammation (Inflammations) 01/2022 - 09/2015
5	Cataract (Cataracts) 07/2020 - 08/2009
3	Heart Failure 01/2024 - 04/2011
3	Hypoxia (Hypoxemia) 11/2022 - 02/2013
3	Hemorrhage 01/2020 - 09/2015
2	Fibrosis (Cirrhosis) 03/2024 - 01/2022
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2024 - 07/2013
2	COVID-19 08/2023 - 11/2022
2	Carcinoma (Carcinomatosis) 04/2023 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2020
2	Septic Shock (Toxic Shock Syndrome) 01/2020 - 05/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 09/2019
2	Atherosclerosis 01/2016 - 01/2011
2	Myopia 08/2012 - 03/2008
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2011 - 01/2011
1	Epilepsy (Aura) 03/2024
1	Status Epilepticus (Complex Partial Status Epilepticus) 03/2024
1	Memory Disorders (Memory Loss) 03/2024
1	Foreign Bodies (Foreign Body) 01/2024
1	Velopharyngeal Insufficiency 12/2023
1	Cleft Palate (Palate, Cleft) 12/2023
1	Nasopharyngeal Carcinoma 10/2023
1	Primary Ovarian Insufficiency 09/2023
1	Prostatic Neoplasms (Prostate Cancer) 07/2023
1	Poisoning 06/2023
1	Aneuploidy (Aneuploid) 01/2023
1	Endometrial Neoplasms (Endometrial Cancer) 01/2023
1	Developmental Dysplasia of the Hip 11/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Adenocarcinoma of Lung 12/2021
1	Chronic Disease (Chronic Diseases) 12/2021
1	Hypertension (High Blood Pressure) 08/2021

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2008
4	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2022
3	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 07/2023 - 03/2008
3	LipopolysaccharidesIBA 11/2018 - 09/2015
2	Pilocarpine (Ocusert)FDA LinkGeneric 03/2024 - 08/2009
2	Glutathione (Reduced Glutathione)IBA 11/2023 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 04/2023 - 12/2021
2	AnticoagulantsIBA 01/2017 - 11/2014
2	ApolipoproteinsIBA 01/2016 - 01/2011
2	Heparin (Liquaemin)FDA LinkGeneric 09/2015 - 11/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2012 - 01/2012
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 08/2011 - 01/2011
1	PolymersIBA 05/2024
1	NaGdF4IBA 05/2024
1	Collagen Type I (Type I Collagen)IBA 03/2024
1	CollagenIBA 03/2024
1	GadoliniumIBA 03/2024
1	Peptide Hydrolases (Proteases)FDA Link 03/2024
1	Serine (L-Serine)FDA Link 03/2024
1	ManganeseIBA 11/2023
1	Malondialdehyde (Propanedial)IBA 11/2023
1	Cisplatin (Platino)FDA LinkGeneric 09/2023
1	CarbonIBA 08/2023
1	AminesIBA 06/2023
1	LigandsIBA 06/2023
1	SolutionsIBA 06/2023
1	MetalsIBA 06/2023
1	SurvivinIBA 04/2023
1	Levonorgestrel (Plan B)FDA LinkGeneric 01/2023
1	MicroRNAs (MicroRNA)IBA 12/2022
1	DNA ProbesIBA 12/2022
1	Lipid PeroxidesIBA 11/2022
1	A 19IBA 11/2022
1	AerosolsIBA 11/2022
1	ElementsIBA 11/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	AlloysIBA 01/2022
1	AntigensIBA 01/2022
1	CholesterolIBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	IonsIBA 01/2022
1	LipidsIBA 01/2022
1	Monomeric GTP-Binding ProteinsIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Insulin (Novolin)FDA Link 08/2021
1	CeramidesIBA 08/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2021
1	GlycogenIBA 08/2021
1	Glucosylceramides (Glucocerebrosides)IBA 08/2021

Therapy/Procedure

5	Therapeutics 11/2023 - 01/2017
3	Precision Medicine 11/2023 - 04/2023
2	Immunotherapy 01/2022 - 12/2021
2	Drug Therapy (Chemotherapy) 12/2021 - 02/2013
1	Heart Transplantation (Grafting, Heart) 01/2024
1	Catheters 01/2024
1	Punctures 01/2024
1	Operative Surgical Procedures 12/2023
1	Chemoradiotherapy 10/2023
1	Induction Chemotherapy 10/2023
1	Hip Prosthesis 11/2022
1	Percutaneous Coronary Intervention 01/2022
1	Wearable Electronic Devices 12/2021
1	Radiotherapy 12/2021